» Articles » PMID: 6659871

Steroid Receptors in Meningiomas. A Histochemical and Biochemical Study

Overview
Specialty Neurology
Date 1983 Jan 1
PMID 6659871
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Meningiomas are more common in females and their course can be affected by changes in the hormonal milieu of the patient. Recently, a few studies have reported the presence of one or more steroid receptors in a small number of meningiomas. We have studied the estrogen and progesterone receptors (ER and PgR) of 11 surgically excised meningiomas. The receptors were assayed biochemically and localized at the cellular level using fluoroceinated estradiol and rhodamine-conjugated progesterone. Considerable amounts of ER were found in 4/11 cases, and PgR was high in 6/11 tumors. Cytoplasmic localization of the steroid binding sites was seen using both tracers. The presence of 10% of cells with two ++ intensity of the fluorescence correlated with tumors having positive ER values (greater than 10 Fm/mg protein). The presence of nuclear fluorescence and the higher level of PgR seen in some tumors indicate that the ER present is functioning. This study confirms the presence of steroid binding sites in meningiomas and suggests that there may be a role for hormonal manipulation in selected patients.

Citing Articles

Osteoblastic meningiomas: clinico-pathological and immunohistochemical features of an uncommon variant.

Barresi V, Caffo M, Ieni A, Alafaci C, Tuccari G J Neurooncol. 2011; 105(2):225-32.

PMID: 21512824 DOI: 10.1007/s11060-011-0588-3.


Sex steroid receptors in human meningiomas.

Blaauw G, Blankenstein M, Lamberts S Acta Neurochir (Wien). 1986; 79(1):42-7.

PMID: 3953323 DOI: 10.1007/BF01403464.


Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study.

Ironside J, Battersby R, Dangerfield V, Parsons M, Timperley W, Underwood J J Clin Pathol. 1986; 39(1):44-50.

PMID: 3950031 PMC: 499611. DOI: 10.1136/jcp.39.1.44.


Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.

Jaaskelainen J, Laasonen E, Karkkainen J, Haltia M, Troupp H Acta Neurochir (Wien). 1986; 80(1-2):35-41.

PMID: 2939693 DOI: 10.1007/BF01809555.


Hormonal modulation of brain tumour growth: a cell culture study.

Gibelli N, Zibera C, Butti G, Assietti R, Sica G, Scerrati M Acta Neurochir (Wien). 1989; 101(3-4):129-33.

PMID: 2618818 DOI: 10.1007/BF01410528.

References
1.
Maynard P, Davies C, Blamey R, Elston C, Johnson J, Griffiths K . Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. Br J Cancer. 1978; 38(6):745-8. PMC: 2009828. DOI: 10.1038/bjc.1978.282. View

2.
Donnell M, Meyer G, DONEGAN W . Estrogen-receptor protein in intracranial meningiomas. J Neurosurg. 1979; 50(4):499-502. DOI: 10.3171/jns.1979.50.4.0499. View

3.
Osborne C, McGuire W . The use of steroïd hormone receptors in the treatment of human breast cancer: a review. Bull Cancer. 1979; 66(3):203-9. View

4.
Lee S . Cellular estrogen and progesterone receptors in mammary carcinoma. Am J Clin Pathol. 1980; 73(3):323-9. DOI: 10.1093/ajcp/73.3.323. View

5.
Furmanski P, Saunders D, Brooks S, Rich M . The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update. Cancer. 1980; 46(12 Suppl):2794-6. DOI: 10.1002/1097-0142(19801215)46:12+<2794::aid-cncr2820461410>3.0.co;2-n. View